Physician profile
Constantine A Toumbis
NPI 1386781409
$1,625,456.53
in general payments reported to CMS, 2019-2025
12 companies · $189K in 2025
The $189K reported for 2025 was more than what 96% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336K · 2020: $279K · 2021: $233K · 2022: $196K · 2023: $180K · 2024: $212K · 2025: $189K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $580K · Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $579,813.56 |
| Food and Beverage | $681.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hyhte Holdings INC. | $995,488.40 | 2019-2025 | Olympic Mis |
| Alphatec Spine, INC | $629,141.46 | 2019-2025 | Arsenal Degenerative, Solanas, Novel |
| Stryker Corporation | $308.16 | 2023-2025 | Autoplex, Spinejack, Canyon Retractor Systems |
| Vb Spine LLC | $187.97 | 2025 | Na |
| Medtronic, INC. | $106.13 | 2022-2025 | Endoskeleton Tc Nanolock Surface Technology, O-Arm |
| Spineology INC. | $67.01 | 2023 | Optimesh Expandable Interbody Fusion System |
| Aesculap Implant Systems, LLC | $47.03 | 2019 | |
| Amgen INC. | $35.93 | 2019 | |
| Merit Medical Systems INC | $24.08 | 2023 | Stabilit |
| Si-Bone, INC. | $23.71 | 2025 | |
| Convatec INC. | $13.79 | 2023 | |
| Zimmer Biomet Holdings, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Toumbis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.